THE EFFECT OF METHOTREXATE ON THE BIOAVAILABILITY OF ORAL 6-MERCAPTOPURINE

被引：68

作者：

BALIS, FM ^{[1
]}

HOLCENBERG, JS ^{[1
]}

ZIMM, S ^{[1
]}

TUBERGEN, D ^{[1
]}

COLLINS, JM ^{[1
]}

MURPHY, RF ^{[1
]}

GILCHRIST, GS ^{[1
]}

HAMMOND, D ^{[1
]}

POPLACK, DG ^{[1
]}

机构：

[1] CHILDRENS CANC STUDY GRP,LOS ANGELES,CA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1987年 / 41卷 / 04期

关键词：

D O I：

10.1038/clpt.1987.45

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：384 / 387

页数：4

相关论文

共 6 条

[1] FALK LC, 1976, CLIN CHEM, V22, P785
[2] GIBALDI M, 1982, PHARMACOKINETICS
[3] LEWIS AS, 1984, J BIOL CHEM, V259, P12
[4] ZIMM S, 1985, CANCER RES, V45, P1869
[5] VARIABLE BIOAVAILABILITY OF ORAL MERCAPTOPURINE - IS MAINTENANCE CHEMOTHERAPY IN ACUTE LYMPHOBLASTIC-LEUKEMIA BEING OPTIMALLY DELIVERED
ZIMM, S
COLLINS, JM
RICCARDI, R
ONEILL, D
NARANG, PK
CHABNER, B
POPLACK, DG
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (17) : 1005 - 1009
[6] INHIBITION OF 1ST-PASS METABOLISM IN CANCER-CHEMOTHERAPY - INTERACTION OF 6-MERCAPTOPURINE AND ALLOPURINOL
ZIMM, S
COLLINS, JM
ONEILL, D
CHABNER, BA
POPLACK, DG
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (06) : 810 - 817